Welcome back to Deep Tech Catalyst, the channel where science meets venture!
We're thrilled to welcome Daniela Drago, Regulatory Expert and Partner at NDA Partners!
Today, we'll dive into the complexities of new drug approval and marketing, exploring the essential criteria required by the United States Food and Drug Administration (FDA) and tackling the challenges and risks associated with IND submissions.
We'll also discuss emerging regulatory trends for 2024 and share valuable advice for those interested in pursuing a career in regulatory affairs.
Let's dive into it!
BEYOND THE CONVERSATION — STRATEGIC INSIGHTS FROM THE EPISODE
Disclaimer
All materials published by The Scenarionist are provided solely for informational and educational purposes. They do not constitute financial, legal, or tax advice, nor do they constitute a recommendation, offer, or solicitation to buy or sell securities, crypto assets, or any other assets. The Scenarionist strives to provide accurate information but does not guarantee that its materials are complete, current, or free from errors, and assumes no liability for any reliance placed on them. Any external partnership or sponsored content will be clearly identified as “Brought to you by.” Unless otherwise disclosed, the companies and technologies mentioned do not sponsor The Scenarionist and are not included in its investment holdings. Artificial intelligence tools may be used for operational support and content refinement.
